NYSE ARCA | ETF
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index.
The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business.
GLP-1 agonists seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 14.90% |
| NVO | Novo Nordisk A/S | Healthcare | Drug Manufacturers - General | 14.22% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 13.83% |
| HIMS | Hims Hers Health Inc | Consumer Defensive | Household & Personal Products | 6.90% |
| 1801 | Innovent Biologics Inc | Healthcare | Biotechnology | 6.39% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 5.90% |
| 4519 | Chugai Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - General | 5.80% |
| TEVA | Teva Pharma Industries Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 5.18% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.79% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 4.68% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 4.65% |
| WST | West Pharmaceutical Services Inc | Healthcare | Medical Instruments & Supplies | 4.63% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.56% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.53% |
| 4901 | Fujifilm Holdings Corp. | Industrials | Conglomerates | 4.17% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.98% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 3.90% |
| 4188 | Mitsubishi Chemical Holdings Corp | Basic Materials | Specialty Chemicals | 3.58% |
| 0O14 | MERCK Kommanditgesellschaft auf Aktien | 3.54% | ||
| ZEAL | Zealand Pharma A/S | Healthcare | Biotechnology | 2.31% |